FDA 483 - Summit Industries Inc. - March 20, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Summit Industries Inc., a medical device manufacturer, revealed significant deficiencies in their quality system. The firm failed to adequately establish and follow corrective and preventive action (CAPA) procedures, with numerous open CAPAs lacking timely completion of actions or root cause analyses. Additionally, production processes for devices like the Radiographic Table were not properly developed, lacking essential work instructions and quality procedures.
ID · 6ba9082b-5cc3-4359-8bc0-99e74b392e5d